Recent News about Indian Generic Semaglutide: Mega thread

- Alkem rolls out 80% cheaper variant of semaglutide in India- https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/alkem-rolls-out-80-cheaper-variant-of-semaglutide-in-india/129715108

- Sun Pharma joins semaglutide race with over 60% cheaper generic: Noveltreat (for weight-loss) will cost patients between Rs 3,490 and Rs 7,400 while Sematrinity (for type-2 diabetes) monthly cost ranges between Rs 2,960 and Rs 4,790. - https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/sun-pharma-joins-semaglutide-race-with-over-60-cheaper-generic/129715627

- USV-Dr Reddy's semaglutide generic hits market at 74,300: The company rolled out its brand "Usema" at starting price of Rs 4,300, in two strengths -2 mg and 4 mg-in a injection pen format. - https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/usv-dr-reddys-semaglutide-generic-hits-market-at-4300/129721908

- Zydus launches semaglutide generic in reusable pen, monthly cost near 72,200 The Ahmedabad-based drugmaker will market a 15 mg reusable pen under the brand names - Semaglyn, Mashema and Altreme. - https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/zydus-launches-semaglutide-generic-in-reusable-pen-monthly-cost-near-2200/129714171

- Glenmark launches semaglutide generic, weekly price staring at 7325 : Glenmark will market both vials and pre-filled pens. Both presentations will be available in strengths of 2 mg, 4 mg, and 8 mg. - https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/glenmark-launches-semaglutide-generic-weekly-price-staring-at-325/129712922

- Dr. Reddy's Laboratories launches Obeda for Type 2 Diabetes The once-weekly injectable therapy is indicated for the management of Type 2 Diabetes and is priced at Rs.4,200 per month. It is available in 2 mg and 4 mg strengths in a pre-filled, disposable pen designed for subcutaneous administration. - https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/dr-reddys-laboratories-launches-obeda-for-type-2-diabetes/129712795

- Doctors advise cautious use of cheap generic anti-obesity medicines: “We have to first check if these companies can maintain the cold chain required f for peptide-based medications such as semaglutide (peptides are sensitive to temperature, needing specific storage to maintain their efficacy)," said Dr Kovil. - https://health.economictimes.indiatimes.com/news/industry/doctors-advise-cautious-use-of-cheap-generic-anti-obesity-medicines/129727883